Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BACE1 | P56817 | 10/20 | 0.37 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.36 |
| ▸ | CTSD | P07339 | 3/20 | 0.35 |
| ▸ | FNTA | P49354 | 4/20 | 0.35 |
| ▸ | FNTB | P49356 | 4/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30390358 | 0.93 | CD274 (0.41) | BACE1OPRD1CTSD | |
| SCHEMBL29421173 | 0.93 | BACE1 (0.38) | BACE1OPRD1CTSDFNTAFNTB | |
| SCHEMBL30567410 | 0.91 | BACE1 (0.38) | BACE1OPRD1CTSDFNTAFNTB | |
| SCHEMBL30254038 | 0.91 | BACE1 (0.38) | BACE1OPRD1CTSDFNTAFNTB | |
| SCHEMBL29630382 | 0.89 | BACE1 (0.36) | BACE1CTSD | |
| SCHEMBL30020949 | 0.89 | BACE1 (0.49) | BACE1OPRD1CTSD | |
| SCHEMBL31474495 | 0.89 | BACE1 (0.33) | BACE1OPRD1 | |
| SCHEMBL30873786 | 0.88 | BACE1 (0.48) | BACE1CTSD | |
| SCHEMBL29630322 | 0.88 | BACE1 (0.41) | BACE1OPRD1CTSD | |
| SCHEMBL29591626 | 0.88 | BACE1 (0.41) | BACE1OPRD1CTSD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116875567-A | Protein-linked zymogen or enzyme from Phyllostachys pubescens and application thereof | 安徽同科生物科技有限公司 | 2023-10-13 | — | — | CN | claimed |
| US-20250179162-A1 | ANTIGEN BINDING FRAGMENTS CONJUGATED TO A PLURALITY OF FC ISOTYPES AND SUBCLASSES | BIO-RAD ABD SEROTEC GMBH (DE) | 2025-06-05 | — | — | US | disclosed |
| CN-113811548-B | Antigen binding proteins | 生物辐射ABD瑟罗泰克有限公司 | 2025-04-04 | — | — | CN | disclosed |
| CN-114746121-B | Pentapeptides and methods of use thereof | 伊利诺伊大学理事会 | 2025-01-10 | — | — | CN | disclosed |
| US-20240409524-A1 | COMPOUND HAVING PHOTOCLEAVABLE MOIETY, CONJUGATE, AND SCREENING METHOD USING SAME | CHUGAI PHARMACEUTICAL CO LTD (JP) | 2024-12-12 | — | — | US | disclosed |
| EP-4378944-A1 | COMPOUND HAVING PHOTOCLEAVABLE SITE, LINKER, AND SCREENING METHOD USING SAME | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2024-06-05 | — | — | EP | disclosed |
| CN-117980308-A | Compound having photocleavable site, joined body, and screening method using same | 中外制药株式会社 | 2024-05-03 | — | — | CN | disclosed |
| US-20240117402-A1 | METHODS FOR (POLY) PEPTIDE TANDEM LIGATION AND CYCLIZATION | NANYANG TECHNOLOGICAL UNIVERSITY (SG) | 2024-04-11 | — | — | US | disclosed |
| EP-4291674-A1 | METHODS FOR (POLY) PEPTIDE TANDEM LIGATION AND CYCLIZATION | Nanyang Technological University (SG) | 2023-12-20 | — | — | EP | disclosed |
| US-20230365656-A1 | A FUSION PROTEIN | THE UNIVERSITY OF QUEENSLAND (NZ) | 2023-11-16 | — | — | US | disclosed |
| WO-2023054636-A1 | COMPOUND HAVING PHOTOCLEAVABLE SITE, LINKER, AND SCREENING METHOD USING SAME | 中外製薬株式会社 | 2023-04-06 | — | — | WO | disclosed |
| EP-4153209-A1 | METHOD FOR TREATING LYSOSOMAL STORAGE DISEASES WITH HISTATIN PEPTIDES | The Board of Trustees of the University of Illinois (US) | 2023-03-29 | — | — | EP | disclosed |
| US-20230027620-A1 | PENTAPEPTIDE AND METHODS OF USE THEREOF | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS | 2023-01-26 | — | — | US | disclosed |
| EP-4065171-A1 | PENTAPEPTIDE AND METHODS OF USE THEREOF | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2022-10-05 | — | — | EP | disclosed |
| WO-2022173377-A1 | METHODS FOR (POLY) PEPTIDE TANDEM LIGATION AND CYCLIZATION | NANYANG TECHNOLOGICAL UNIVERSITY (SG) | 2022-08-18 | — | — | WO | disclosed |
| CN-108602852-B | Histamine and methods of use thereof | 伊利诺伊大学理事会 | 2022-07-22 | — | — | CN | disclosed |
| CN-114746121-A | Pentapeptides and methods of use thereof | 伊利诺伊大学理事会 | 2022-07-12 | — | — | CN | disclosed |
| US-11370816-B2 | Histatins and method of use thereof | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2022-06-28 | — | — | US | disclosed |
| CN-106459160-B | ASX-specific protein ligases | 南洋理工大学 | 2022-03-29 | — | — | CN | disclosed |
| EP-3941485-A1 | ANTIGEN BINDING PROTEINS | Bio-Rad ABD Serotec GmbH (DE) | 2022-01-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240409524-A1 | COMPOUND HAVING PHOTOCLEAVABLE MOIETY, CONJUGATE, AND SCREENING METHOD USING SAME | ALDH1A2, FOLH1, TACR1 | BACE1 1578/4885OPRD1 1993/4885CTSD 1535/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.